Table 1.
Baseline demographic and clinical characteristics of the study groups.
| Variable | Coronary artery disease progression | p-value | |
|---|---|---|---|
| Yes(n = 58) | No(n = 128) | ||
| Age (years) | 65 (58-71) | 58 (52-70) | 0.057 |
| Male % | 45 (78.5) | 94 (73.4) | 0.141 |
| Hypertension % | 31 (53.4) | 40 (31.1) | 0.025 |
| Diabetes mellitus % | 30 (51.7) | 32 (25) | 0.003 |
| Smoking % | 28 (43.1) | 54 (42.2) | 0.906 |
| Hyperlipidemia % | 40 (69) | 45 (35) | <0.001 |
| Nondipper hypertension | 34 (58.1) | 37 (28.9) | <0.001 |
| BMI (kg/m2) | 24.4 ± 2.7 | 25.9 ± 2.3 | 0.463 |
| GFR mL/min/1.73 m2 | 94.2 ± 20.5 | 93.1 ± 20.5 | 0.756 |
| Plasma creatinine | 0.8 ± 0.2 | 0.8 ± 0.1 | 0.110 |
| Aspartate aminotransferase | 37.5 ± 32.8 | 37 ± 29.8 | 0.920 |
| Alanine aminotransferase | 26.5 ± 18.7 | 29.3 ± 24.9 | 0.440 |
| Total protein | 7.1 ± 2.5 | 6.7 ± 2.2 | 0.420 |
| Plasma Albumin (g/dL) | 3.9 ± 1.5 | 3.8 ± 1.9 | 0.741 |
| Total cholesterol (mg/dL) | 201.4 ± 46.3 | 176.3 ± 39 | <0.001 |
| Triglyceride (mg/dL) | 161.8 ± 78.9 | 151.2 ± 81.5 | 0.402 |
| HDL cholesterol (mg/dL) | 37.5 ± 10.2 | 35.9 ± 13 | 0.383 |
| LDL cholesterol (mg/dL) | 117 ± 37.1 | 110.1 ± 34.3 | 0.013 |
| Sodium (mg/dL) | 139 ± 7.3 | 138.2 ± 5.9 | 0.415 |
| Potassium (mg/dL) | 4.3 ± 0.46 | 4.6 ± 3.1 | 0.420 |
| Calcium (mg/dL) | 8.8 ± 0.6 | 8.8 ± 1.1 | 0.990 |
| White blood cell (103/µL) | 16.4 ± 4.7 | 14.1 ± 3.1 | 0.330 |
| Hgb (g/dL) | 14.1 ± 2 | 14.3 ± 1.8 | 0.550 |
| Platelet (103/µL) | 258.4 ± 80.5 | 251.2 ± 80.9 | 0.560 |
| Pletacrit (%) | 0.26 ± 0.07 | 0.26 ± 0.03 | 0.640 |
| RDW-CV (%) | 15.1 ± 9.36 | 15.28 ± 8.96 | 0.900 |
| CRP (mg/dL) | 10.7 ± 3.1 | 6.2 ± 2.5 | 0.001 |